Table IV.
Relative Potencies of Topical Corticosteroids*
Class | Drug | Dosage Form(s) | Strength (%) |
---|---|---|---|
I. Very High Potency | Augmented betamethasone dipropionate | Ointment | 0.05 |
Clobetasol propionate | Cream, foam, ointment | 0.05 | |
Diflorasone diacetate | Ointment | 0.05 | |
Halobetasol propionate | Cream, ointment | 0.05 | |
II. High Potency | Amcinonide | Cream, lotion, ointment | 0.1 |
Augmented betamethasone dipropionate | Cream | 0.05 | |
Betamethasone dipropionate | Cream, foam, ointment, solution | 0.05 | |
Desoximetasone | Cream, ointment | 0.25 | |
Desoximetasone | Gel | 0.05 | |
Diflorasone diacetate | Cream | 0.05 | |
Fluocinonide | Cream, gel, ointment, solution | 0.05 | |
Halcinonide | Cream, ointment | 0.1 | |
Mometasone furoate | Ointment | 0.1 | |
Triamcinolone acetonide | Cream, ointment | 0.5 | |
III-IV. Medium Potency | Betamethasone valerate | Cream, foam, lotion, ointment | 0.1 |
Clocortolone pivalate | Cream | 0.1 | |
Desoximetasone | Cream | 0.05 | |
Fluocinolone acetonide | Cream, ointment | 0.025 | |
Flurandrenolide | Cream, ointment | 0.05 | |
Fluticasone propionate | Cream | 0.05 | |
Fluticasone propionate | Ointment | 0.005 | |
Mometasone furoate | Cream | 0.1 | |
Triamcinolone acetonide | Cream, ointment | 0.1 | |
V. Lower-Medium Potency | Hydrocortisone butyrate | Cream, ointment, solution | 0.1 |
Hydrocortisone probutate | Cream | 0.1 | |
Hydrocortisone valerate | Cream, ointment | 0.2 | |
Prednicarbate | Cream | 0.1 | |
VI. Low Potency | Alclometasone dipropionate | Cream, ointment | 0.05 |
Desonide | Cream, gel, foam, ointment | 0.05 | |
Fluocinolone acetonide | Cream, solution | 0.01 | |
VII. Lowest Potency | Dexamethasone | Cream | 0.1 |
Hydrocortisone | Cream, lotion, ointment, solution | 0.25, 0.5, 1 | |
Hydrocortisone acetate | Cream, ointment | 0.5–1 |
Reprinted with permission from Paller AS, Mancini AJ. Eczematous eruptions in childhood. In: Paller AS, Mancini AJ. Hurwitz Clinical Pediatric Dermatology. St. Louis, MO: Elsevier Inc; 2011 chapter 3, p.49.
Includes representative examples and not all available agent